Condition
Type 2 Diabetes: medications and paying cash
Type 2 diabetes medications help control blood sugar levels and reduce the risk of diabetes-related complications.
Overview
Type 2 diabetes is high blood sugar caused by the body responding poorly to its own insulin and, over time, making less of it. Treatment aims to keep blood sugar in a range that prevents damage to the eyes, kidneys, nerves and blood vessels, and increasingly to protect the heart and kidneys directly.
Metformin remains the first medicine for nearly everyone because it is effective, safe and costs very little. Beyond metformin the choice depends on what else the patient has. SGLT2 inhibitors such as empagliflozin are favored when there is heart failure or kidney disease; GLP-1 agonists such as semaglutide and dulaglutide when weight or cardiovascular risk is the concern; DPP-4 inhibitors such as sitagliptin for a gentle add-on; sulfonylureas such as glipizide where cost is the overriding issue; and insulin when the others are not enough.
Most people will take two or three of these over time, and the prescriber will reassess as blood sugar, weight, kidney function and heart risk change.
Choosing between the options when you pay cash
This is the condition where the cash-pay picture is most uneven. Metformin, glipizide and the older insulins cost pharmacies very little, and their cash prices are mostly dispensing fees. The SGLT2 and DPP-4 tablets and the GLP-1 injections are brand products, or are only beginning to see generic competition, so they are priced at a different order of magnitude. A patient paying cash can be on a combination that costs almost nothing or one that costs a great deal, for similar blood sugar control.
Three practical points follow. First, ask the prescriber which parts of the regimen are doing the clinical work; a brand add-on with a modest effect may be the one to question. Second, for the brand drugs, the manufacturers’ assistance programs for uninsured patients are the first thing to check, before any pharmacy comparison. Third, combination tablets that bundle a brand with metformin are convenient but can cost more than the two prescriptions separately; ask for both quotes.
When paying cash beats a copay, and when it does not
For metformin, glipizide and the older human insulins, a cash quote from an independent or mail-order pharmacy is often below a copay, and some pharmacies list them at a flat price. For the brand SGLT2, DPP-4 and GLP-1 drugs, insurance with the manufacturer co-pay card is almost always cheaper than cash; a cash-paying patient on those should look at patient assistance before paying list price.
Common symptoms
- Increased thirst
- Frequent urination
- Fatigue
- Blurred vision
Medicines at a glance
How the medicines in this group are supplied and usually taken. Each guide has the full details.
- MetforminImmediate-release tablet, Extended-release tablet (several non-interchangeable types), Oral solution (Riomet)Generic: Yes · Two or three times a day with meals, or once a day extended-release
- EmpagliflozinTablet, Combination tablets with metformin (Synjardy), linagliptin (Glyxambi) and both (Trijardy XR)Generic: No · Once a day
- SemaglutidePrefilled multi-dose injection pen (Ozempic, Wegovy), Single-dose injection pen (Wegovy), Tablet (Rybelsus)Generic: No · Once a week
- DulaglutideSingle-dose prefilled pen, injected once weeklyGeneric: No · Once a week
- SitagliptinTablet, Combination tablets with metformin (Janumet, Janumet XR)Generic: Yes · Once a day
- GlipizideImmediate-release tablet, Extended-release tabletGeneric: Yes · See the guide
- Insulin GlarginePrefilled injection pen, Vial for use with insulin syringesGeneric: Yes · Once a day
- TirzepatideSingle-dose prefilled injection pen (Mounjaro, Zepbound), Single-dose vials (Zepbound, sold through the manufacturer’s self-pay channel)Generic: No · Once a week
- LinagliptinTablets, Combination tablets with metformin, empagliflozin, or bothGeneric: No · Once a day
- GlyburideTablets, Micronized tablets, Tablets combined with metforminGeneric: Yes · Once a day
- CanagliflozinTablets (Invokana), Tablets with metformin (Invokamet), Extended-release tablets with metformin (Invokamet XR)Generic: No · Once a day
- LiraglutidePrefilled multi-dose injection penGeneric: Yes · Once a day
- GlimepirideTabletsGeneric: Yes · Once a day
- DapagliflozinTabletsGeneric: Yes · Once a day
- PioglitazoneTabletsGeneric: Yes · Once a day
- Insulin LisproVials, Prefilled pens, CartridgesGeneric: No · See the guide
- Insulin AspartVials, Prefilled pens, PenFill cartridgesGeneric: Yes · See the guide
- Insulin DegludecVial, FlexTouch pen, U-100, FlexTouch pen, U-200Generic: No · Once a day
| Medicine | Forms | Generic | Usually taken |
|---|---|---|---|
| Metformin | Immediate-release tablet, Extended-release tablet (several non-interchangeable types), Oral solution (Riomet) | Yes | Two or three times a day with meals, or once a day extended-release |
| Empagliflozin | Tablet, Combination tablets with metformin (Synjardy), linagliptin (Glyxambi) and both (Trijardy XR) | No | Once a day |
| Semaglutide | Prefilled multi-dose injection pen (Ozempic, Wegovy), Single-dose injection pen (Wegovy), Tablet (Rybelsus) | No | Once a week |
| Dulaglutide | Single-dose prefilled pen, injected once weekly | No | Once a week |
| Sitagliptin | Tablet, Combination tablets with metformin (Janumet, Janumet XR) | Yes | Once a day |
| Glipizide | Immediate-release tablet, Extended-release tablet | Yes | See the guide |
| Insulin Glargine | Prefilled injection pen, Vial for use with insulin syringes | Yes | Once a day |
| Tirzepatide | Single-dose prefilled injection pen (Mounjaro, Zepbound), Single-dose vials (Zepbound, sold through the manufacturer’s self-pay channel) | No | Once a week |
| Linagliptin | Tablets, Combination tablets with metformin, empagliflozin, or both | No | Once a day |
| Glyburide | Tablets, Micronized tablets, Tablets combined with metformin | Yes | Once a day |
| Canagliflozin | Tablets (Invokana), Tablets with metformin (Invokamet), Extended-release tablets with metformin (Invokamet XR) | No | Once a day |
| Liraglutide | Prefilled multi-dose injection pen | Yes | Once a day |
| Glimepiride | Tablets | Yes | Once a day |
| Dapagliflozin | Tablets | Yes | Once a day |
| Pioglitazone | Tablets | Yes | Once a day |
| Insulin Lispro | Vials, Prefilled pens, Cartridges | No | See the guide |
| Insulin Aspart | Vials, Prefilled pens, PenFill cartridges | Yes | See the guide |
| Insulin Degludec | Vial, FlexTouch pen, U-100, FlexTouch pen, U-200 | No | Once a day |
Medications
Which of these is right for a given person is a decision for the prescriber. The guides explain what each drug is, how it is supplied, and why its cash price varies between pharmacies. No page on this site shows a price; prices come from pharmacies responding to your actual prescription.
Questions worth asking
- Which of my medicines is doing most of the work, and could any be replaced by a cheaper class?
- Is there a reason I need the combination tablet rather than the two components?
- Do I qualify for the manufacturer assistance program for my brand medicine?
- How often should my kidney function and A1c be checked on this regimen?
- What should I do about low blood sugar if I take glipizide or insulin?
How Script Unlock gets you a cash price for a type 2 diabetes medication
Prices on this site come from pharmacies responding to a real prescription. We do not publish estimated, average or "typical" prices, because none of those would be your price.
- 1You upload your prescription
A photo of your a type 2 diabetes medication prescription is enough. Nothing is sold on the site; you are asking pharmacies to quote.
- 2Licensed pharmacies respond
Pharmacies that Script Unlock has verified see the request and each can reply with its own cash price for your exact drug, strength and quantity.
- 3You choose and pay the pharmacy
You compare the responses, pick a pharmacy, and pay that pharmacy directly when you collect. Script Unlock never takes a patient payment and never sets the price.
Related
Sources
- National Institute of Diabetes and Digestive and Kidney Diseases
- MedlinePlus health topics (NIH)
- MedlinePlus drug information (National Library of Medicine)
- FDA Orange Book (approved generics and therapeutic equivalence)
Written by the Script Unlock editorial team from the sources above. Not yet reviewed by an independent pharmacist. Last checked 2026-10-03.
Script Unlock is a marketplace that lets licensed pharmacies quote a cash price on your prescription. It does not prescribe, dispense or sell medication, does not process patient payments, and does not give medical advice. Always follow the instructions of your prescriber and pharmacist and read the medication guide supplied with your medicine.